Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ligand Pharma (LGND)
NASDAQ:LGND
Ligand Pharma (LGND) Ownership - Who Owns Ligand Pharma?
749 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 27, 2024 | Todd Davis Ceo,director | Bought | $919147 |
| Mar 06, 2024 | Jason Aryeh Director | Bought | $113840 |
| Sep 25, 2023 | Todd Davis Ceo,director | Bought | $237520 |
| May 18, 2023 | John Kozarich Director | Sold | $343077 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Sold | $298749 | |
| Dec 31, 2023 | Bought | $1303415 | |
| Dec 31, 2023 | Bought | $1439898 | |
| Dec 31, 2023 | Bought | $3520791 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,180,050 | Institution | 12.31% | 171,940,544 | |
| 1,697,014 | Institution | 9.58% | 133,843,494 | |
| 1,450,664 | Institution | 8.19% | 114,413,870 | |
| 1,265,918 | Insider | 7.15% | 99,842,953 | |
| 1,229,247 | Institution | 6.94% | 96,950,711 | |
| 740,914 | Institution | 4.18% | 58,435,887 | |
| 417,695 | Insider | 2.36% | 32,943,605 | |
| 363,796 | Institution | 2.05% | 28,692,591 | |
| 304,080 | Institution | 1.72% | 23,982,790 | |
| 302,279 | Institution | 1.71% | 23,840,745 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,450,664 | Institution | 8.19% | 114,413,870 | |
| 1,229,247 | Institution | 6.94% | 96,950,711 | |
| 740,914 | Institution | 4.18% | 58,435,887 | |
| 363,796 | Institution | 2.05% | 28,692,591 | |
| 302,279 | Institution | 1.71% | 23,840,745 | |
| 205,208 | Institution | 1.16% | 16,184,755 | |
| 183,766 | Institution | 1.04% | 14,493,624 | |
| 160,405 | Institution | 0.91% | 12,651,142 | |
| 159,157 | Institution | 0.90% | 12,552,713 | |
| 135,482 | Institution | 0.77% | 10,685,465 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,102,222 | Institution | 6.23% | 79,933,139 | |
| 501,975 | Institution | 2.84% | 36,694,373 | |
| 423,621 | Institution | 2.39% | 30,966,695 | |
| 398,404 | Institution | 2.25% | 28,892,258 | |
| 283,592 | Institution | 1.60% | 20,730,575 | |
| 245,341 | Institution | 1.39% | 17,934,427 | |
| 198,620 | Institution | 1.12% | 14,403,922 | |
| 145,531 | Institution | 0.82% | 11,478,030 | |
| 136,045 | Institution | 0.77% | 9,865,983 | |
| 134,992 | Institution | 0.76% | 9,789,620 |
FAQ
Who Owns Ligand Pharma (LGND)?
Currently, no data Available
What percentage of Ligand Pharma (LGND) stock is held by institutional investors?
Currently, no data Available
What percentage of Ligand Pharma (LGND) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Ligand Pharma (LGND)?
iShares owns the most shares of Ligand Pharma (LGND).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.